124 results
Page 3 of 7
8-K
EX-99.1
eh3bkou5k 3w
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
8-K
EX-10.1
w6lxktnz
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
424B5
fxamnmhc 4x0vpr5xrhb
4 Apr 23
Prospectus supplement for primary offering
6:03am
8-K
EX-99.1
y3db epuz
31 Mar 23
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
6:00am
8-K
EX-10.1
kk26t2onkcz 49702pj
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
8-K
EX-99.1
32q v6jda
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
424B5
1smcghn6vwmm6aerm
16 Dec 22
Prospectus supplement for primary offering
7:00am
8-K
EX-99.1
1aqyy6cyyp5
5 Dec 22
Checkpoint Therapeutics Announces Reverse Stock Split
4:45pm
DEF 14C
v9bucb3vnsgwfh
14 Nov 22
Information statement
5:00pm
8-K
EX-99.1
ifdajgbk2rb14te2sxv
8 Nov 22
Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
5:43pm
PRE 14C
m16a10wwi8u7wg938
4 Nov 22
Preliminary information
5:22pm
8-K
EX-99.1
1nzy8 wcuwatjwr
12 Aug 22
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:15am
8-K
EX-99.1
2nvikr8k3fihyd
16 Jun 22
Other Events
7:45am
8-K
EX-99.1
p8hli o8cq
12 May 22
Checkpoint Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
4:45pm